Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 33 of Minerva Neurosciences, Inc.'s SEC filings and found 4 warrant series, 1 convertible, 1 ATM program, 2 shelf registrations and 3 completed offerings on file for NERV. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Nov 1, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
NMRANeumora Therapeutics, Inc. Common Stock
LENZLENZ Therapeutics, Inc.
PYPDPolyPid Ltd. Ordinary Shares
HURATuHURA Biosciences, Inc.
AVXLAnavex Life Sciences Corp.
VYGRVoyager Therapeutics, Inc.
NKTXNkarta, Inc.
OTLKOutlook Therapeutics, Inc.
ARMPArmata Pharmaceuticals, Inc.
CDXSCodexis, Inc.
HUMAHumacyte, Inc.
NBPNovaBridge Biosciences
EQEquillium, Inc.
KZIAKazia Therapeutics Limited American Depositary Shares
ANIXAnixa Biosciences, Inc.